Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
0.6300 CAD | +1.61% | -3.08% | -49.60% |
11-10 | Toronto Stocks Inch Lower; AtkinsRealis Rises on 3Q Beat | DJ |
11-10 | Piper Sandler On Aurora Cannabis | MT |
Sales 2023 | 175 M 130 M | Sales 2024 * | 272 M 201 M | Capitalization | 295 M 218 M |
---|---|---|---|---|---|
Net income 2023 | -199 M -147 M | Net income 2024 * | -48.00 M -35.53 M | EV / Sales 2023 | 1,00x |
Net cash position 2023 | 73.32 M 54.28 M | Net cash position 2024 * | 133 M 98.46 M | EV / Sales 2024 * | 0,59x |
P/E ratio 2023 | -1,13x | P/E ratio 2024 * | -4,97x | Employees | 1,338 |
Yield 2023 | - | Yield 2024 * | - | Free-Float | 99.97% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
1 day | +1.61% | ||
1 week | -3.08% | ||
Current month | +1.61% | ||
1 month | -1.56% | ||
3 months | -3.08% | ||
6 months | -5.97% | ||
Current year | -49.60% |
1 week
0.60
0.65

1 month
0.60
0.71

Current year
0.56
1.59

1 year
0.56
1.99

3 years
0.56
24.10

5 years
0.56
164.04

10 years
0.56
194.88

Managers | Title | Age | Since |
---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 51 | 2020 |
Glen Ibbott
DFI | Director of Finance/CFO | 60 | 2017 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Funk
CHM | Chairman | 66 | 2018 |
Michael Singer
BRD | Director/Board Member | 59 | 2016 |
Adam Szweras
BRD | Director/Board Member | 51 | 2015 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.83% | 27 M€ | -48.88% | - | |
3.29% | 186 M€ | -24.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
23-12-01 | 0.6300 | +1.61% | 774,196 |
23-11-30 | 0.6200 | 0.00% | 1,026,548 |
23-11-29 | 0.6200 | 0.00% | 425,280 |
23-11-28 | 0.6200 | -1.59% | 353,326 |
23-11-27 | 0.6300 | -3.08% | 632,209 |
Delayed Quote Toronto Stock Exchange, December 01, 2023 at 04:00 pm
More quotes
Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Companyâs segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Bradford Ontario, Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.
Sector
Pharmaceuticals
Calendar
2024-02-07
- Q3 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
D+
Sell
Buy

Mean consensus
HOLD
Number of Analysts
10
Last Close Price
0.6300CAD
Average target price
1.062CAD
Spread / Average Target
+68.61%
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.60% | 217 M $ | |
-16.96% | 5 881 M $ | |
+25.11% | 4 548 M $ | |
+82.30% | 3 284 M $ | |
+42.10% | 3 205 M $ | |
-15.14% | 2 784 M $ | |
+13.01% | 2 024 M $ | |
-20.42% | 1 869 M $ | |
+4.60% | 1 782 M $ | |
+1.23% | 1 608 M $ |

MarketScreener is also available in United States.
Switch edition
Stay in the current country edition